Verve Therapeutics Inc. (VERV)
5.38
0.13 (2.48%)
At close: Jan 15, 2025, 12:32 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -200.07M | -157.39M | -120.31M | -45.70M | -19.30M |
| Depreciation & Amortization | 5.46M | 2.80M | 1.53M | 1.33M | 106.00K |
| Stock-Based Compensation | 35.12M | 22.48M | 7.07M | 850.00K | 446.00K |
| Other Working Capital | 13.79M | 13.60M | -9.74M | 4.54M | 926.00K |
| Other Non-Cash Items | -7.75M | 1.39M | 35.23M | 5.24M | 8.71M |
| Deferred Income Tax | n/a | n/a | 1.51M | 380.00K | -72.00K |
| Change in Working Capital | 17.70M | 8.38M | -2.91M | 2.64M | 2.66M |
| Operating Cash Flow | -149.55M | -122.33M | -77.88M | -35.27M | -7.44M |
| Capital Expenditures | -9.28M | -13.23M | -4.36M | -3.42M | -1.86M |
| Acquisitions | n/a | 142.72M | 234.74M | 47.70M | 10.90M |
| Purchase of Investments | -517.14M | -479.40M | -371.49M | -98.48M | -22.00M |
| Sales Maturities Of Investments | 554.11M | 336.68M | 136.75M | 50.78M | 11.10M |
| Other Investing Acitivies | n/a | -142.72M | -234.74M | -47.70M | -10.90M |
| Investing Cash Flow | 27.69M | -155.96M | -239.10M | -51.13M | -12.76M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.12M | 2.46M | 91.88M | 92.63M | 17.95M |
| Financial Cash Flow | 212.58M | 328.96M | 377.09M | 92.63M | 17.95M |
| Net Cash Flow | 90.72M | 50.67M | 60.11M | 6.24M | -2.25M |
| Free Cash Flow | -158.83M | -135.56M | -82.24M | -38.69M | -9.30M |